PHOTOREACTIVATION ASSOCIATED WITH CHROMOSOMAL ABNORMALITY IN SEA URCHIN EGGS FERTILIZED WITH ULTRAVIOLET-IRRADIATED SPERM

Abstract— As a model for studies involving biologic systems, rates of hematoporphyrin and protopor-phyrin-sensitized photooxidation of tryptophan were measured in water-methanol mixtures. Absorption and fluorescence-emission spectra associated with solutions of porphyrins in different water-methano! mixtures were also examined. The optimal rate of photooxidation by hematoporphyrin occurred in 30% methanol; by protoporphyrin, in 60% methanol. Absorption spectra were examined to characterize dispersion of hematoporphyrin into monomeric form in 90% methanol, and the dimer formation which predominates in 30% methanol. With the more hydrophobic protoporphyrin, an absorption spectrum characteristic of drug monomer was seen in 100% methanol, a dimer spectrum was observed in 60% methanol. At methanol concentrations < 60%, we observed impaired photooxidation and another alteration in the absorption pattern apparently reflecting drug aggregation beyond the dimer stage. Fluorescence emission maxima of both porphyrins were blue-shifted with increasing solvent dielectric constant, but an additional blue shift was detected in an aqueous environment which was apparently related to porphyrin aggregation. Absorption and fluorescence-emission spectra appear helpful for characterizing environmental determinants of porphyrin-sensitized photooxidation.     

High pressure and high temperature investigations in the system MgOSiO2H2O

The system MgOSiO₂H₂O was investigated at pressures between 40 and 95 kbar and at temperatures between 500 and 1400°C. The reaction products were examined by X-ray, optical and thermal analysis techniques and the density of phase A discovered by Ringwood and Major was also measured. It was found that phase A was hydrated and its chemical formula was H₆Mg₇Si₂O₁₄. When the $\text{Mg}\text{Si}$ ratio of the system is 2, phase A + clinoenstatite, and forsterite are stable at temperatures lower and higher than a boundary curve T (°C) = 10P (kbar), respectively. When the $\text{Mg}\text{Si}$ ratio of the system is 3, phase A + phase D (which is completely different from the phases, A, B and C discovered by Ringwood and Major, and any other known phases of magnesium silicate) and phase D + brucite are stable at temperatures lower and higher than a boundary curve T(°C) = 10P (kbar) + 200. Phase A has approximately an hexagonal symmetry and the space group and the lattice parameters are determined as P6₃ or $\text{P6}{}_3\text{m}$ and a = 7.866(2) Å and c = 9.600(3) Å, respectively. The measured density is 2.96 ± 0.02 g/cm³. The optical observations show that phase A is biaxial positive crystal with refractive indices α = 1.638 ± 0.001, β = 1.640 ± 0.002, and γ = 1.649 ± 0.001. Some interpretation is given on the inconsistency between the symmetry determined by the X-ray diffraction and the optical observation. The new phase D belongs to the space group $\text{P2}{}_1\text{c}$ with lattice parameters a = 7.914(2)Å, b = 4.752(1) Å, c = 10.350(2) Å and β = 108.71(5)° and is a biaxial crystal with refractive indices α = 1.630 ± 0.002, β = 1.642 ± 0.002 and γ = 1.658 ± 0.001.     

Non-glutamate type pyrrolo[2,3-d]pyrimidine antifolates. III. Synthesis and biological properties of N(omega)-masked ornithine analogs

The glutamic acid moiety of N-[4-[3-(2,4-diamino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)propyl]benzoyl]-L-g lutamic acid (1b, TNP-351) and the related compound (1a), was replaced with various N(omega)-acyl-, sulfonyl-, carbamoyl- and aryl-2,omega-diaminoalkanoic acids, and the inhibitory effects of the resulting products (9, 11, 14, 18, 21, 23, 25, 30, 36) on dihydrofolate reductase (DHFR), the growth of murine fibrosarcoma Meth A cells, and methotrexate-resistant human CCRF-CEM cells, were examined. Compounds (9a-f) acylated with a hemiphthaloyl group were efficiently synthesized by coupling pyrrolo[2,3-d]pyrimidine carboxylic acids (7a,b) and N(omega)-phthaloyl 2,omega-diaminoalkanoic acid methyl esters (6a-c) and subsequent hydrolysis. The other N(omega)-acyl- and sulfonyl-ornithine analogs (21, 23, 25) were synthesized by acylation of free amino intermediates (19a,b) derived from tert-butoxycarbonyl-ornithine analogs (17a,b). A free ornithine analog (18) did not strongly inhibit Meth A cell growth, whereas all N(omega)-acyl-, sulfonyl-, carbamoyl- and aryl-ornithine analogs (9, 11, 21, 23, 25, 30, 36) exhibited much more potent inhibitory activities against both DHFR and Meth A cell growth. In particular, compounds 9c, 21k and 36a also showed remarkable growth-inhibitory activities against methotrexate-resistant CCRF-CEM cells. These results demonstrate that the potent inhibitory activities of N(omega)-masked ornithine analogs against the growth of Meth A cells and methotrexate-resistant CCRF-CEM cells, results from effective uptake via reduced folate carrier and their potent DHFR inhibition.     

Negative ion mass spectra of chlorine-containing molecules

The negative ion mass spectra of chlorine-containing molecules have been measured using a double focusing mass spectrometer with a photographic plate detector. The formulae of the negative ions not previously assigned using an electron multiplier detector have now been assigned.     

Polymerization of vinyl chloride and copolymerization with propylene by a ternary catalyst system

Polymerization of vinyl chloride by the ternary catalyst system of VOCl₃–AIR_nCl_3–n complexing agent was investigated. It was suggested that the formation of a polar complex (or charge-transfer complex) between AlR_nCl_3–n and the complexing agent participated in the polymerization of vinyl chloride. In the copolymerization of vinyl chloride with propylene with the present catalyst system, it was more difficult to incorporate the propylene unit in the copolymer than with a typical radical catalyst.